Chronic kidney disease in the elderly--how to assess risk
about
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKDRecommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart AssociationPrevalence of chronic kidney disease and its related risk factors in elderly of southern iran: a population-based study.Chronic kidney disease and osteoporosis: evaluation and management.Plasma cystatin C and acute kidney injury after cardiopulmonary bypass.Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation.Potentially inappropriate prescribing of primarily renally cleared medications for older veterans affairs nursing home patientsChronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significanceAdvances in glomerular filtration rate-estimating equationsSerum cystatin C - marker of inflammation and cardiovascular morbidity in chronic kidney disease stages 1-4Chronic kidney disease and the skeleton.The antioxidative effects of acidic-, alkalic-, and enzymatic-extractable mycelium zinc polysaccharides by Pleurotus djamor on liver and kidney of streptozocin-induced diabetic miceComparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals.Factors other than glomerular filtration rate affect serum cystatin C levels.Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).Cystatin C and risk of hip fractures in older womenChronic kidney disease (CKD) in the elderly -- a geriatrician's perspective.High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine.Consensus guidelines for oral dosing of primarily renally cleared medications in older adults.Computerized clinical decision support during medication ordering for long-term care residents with renal insufficiencyCystatin C: current position and future prospects.Pharmacotherapy of heart failure in the elderly: adverse events.Why did I start dialysis? A qualitative study on views and expectations from an elderly cohort of patients with end-stage renal failure starting haemodialysis in the United Kingdom.New prescriptions of spironolactone associated with angiotensin-converting-enzyme inhibitors and/or angiotensin receptor blockers and their laboratory monitoring from 2001 to 2008: a population study on older people living in the community in Italy.Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings.Protective effects on liver, kidney and pancreas of enzymatic- and acidic-hydrolysis of polysaccharides by spent mushroom compost (Hypsizigus marmoreus).Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial.Antihyperglycaemic and organic protective effects on pancreas, liver and kidney by polysaccharides from Hericium erinaceus SG-02 in streptozotocin-induced diabetic mice.Fracture risk in CKD.Cystatin C and cardiac hypertrophy in primary hypertension.Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status.The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations.A comparison of cystatin C concentrations between patients with chronic interstitial nephritis and glomerular diseases.MAT, a Novel Polyherbal Aphrodisiac Formulation, Enhances Sexual Function and Nrf2/HO-1 Pathway While Reducing Oxidative Damage in Male Rats.Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography
P2860
Q24652643-04A16DA0-832B-48C8-9649-440AB9087105Q30666157-7C1E425E-3A9F-4357-9989-9F10AD63A58DQ33710862-7A3D1090-31BD-49A2-B0A8-298869181062Q33833414-518A4ED8-4F9A-415E-A3B7-49AA71B232A5Q34075458-1615D194-655F-4ACA-9B5E-77423642B033Q34772421-DC44DB35-B8CC-4FE3-B43A-7CD45970FA78Q35007528-EDA3E664-2F2E-4BEC-8C95-CF0472721F42Q35176802-FB75D7A3-E629-44D2-9D94-E7FE30282786Q35334993-BCFE3DE4-44B7-40BB-9D00-14743798B93BQ35508233-EF500D87-A7A6-4CD3-9DB9-383EE8570361Q35755179-F76C3BAB-418A-457F-B051-54AB1AAA6F1EQ35873054-CAA03D7F-AAD8-487E-B457-3EDB0A2602C3Q35903122-060BEEF5-07D9-473F-AC0A-3D4C17EABFC2Q36020086-BAEA4303-610E-45A8-AEA7-EAA2C0DA55E4Q36071729-DC9DBD26-B9A0-40DA-852C-71258371E24FQ36821470-88D3D215-EAF1-4F53-908F-385D7652099FQ36911521-DEA67571-23C4-4D68-91C1-73A37CE627F7Q37024559-47ECAD90-DA3E-4B6C-99D7-F7741EF62A0CQ37093020-87121543-7CD0-4AF3-A401-2107BAB1A7E4Q37249191-2CBCD27E-82A2-431E-ADB0-810E7E572AD7Q37313436-4BDFA5BC-B899-4523-ADBC-703315626D10Q37891877-6CA26B5F-A26A-4E8D-9A3E-51BB92E65328Q37919373-28F33A8B-51D6-4684-8ABA-34AEC0673CCCQ38045164-E21DE107-95DC-40D4-A68B-323952D381BEQ38450329-812AFDC8-5928-45EB-9AFC-D8D1008F9EC1Q40446288-1680DC54-06B1-4965-A6F1-79B2AE5F88BFQ41452418-DC020090-B052-413E-8DE2-1DB140F6AD32Q41542102-26A4689C-B539-4F0F-995E-9293E8B22F01Q43063365-06D23DBE-0782-4F0B-B9D3-30A5708781FFQ43180532-6EE53DE3-2B24-4CC6-9E2A-A42416BE882FQ46495930-2EF62DFD-BD47-45D6-A89C-72D5F2F34AD2Q46851869-2C849381-DBC6-423C-8D42-612805E0BA6BQ47976324-02F110BE-15E4-4430-8A77-D97D1E7A23A9Q55438745-0C1E78BD-DDE8-48BC-86C1-51D0D5B92F27Q59049724-649AB683-91BB-4366-8A96-D7E19A8AECCB
P2860
Chronic kidney disease in the elderly--how to assess risk
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Chronic kidney disease in the elderly--how to assess risk
@ast
Chronic kidney disease in the elderly--how to assess risk
@en
Chronic kidney disease in the elderly--how to assess risk
@nl
type
label
Chronic kidney disease in the elderly--how to assess risk
@ast
Chronic kidney disease in the elderly--how to assess risk
@en
Chronic kidney disease in the elderly--how to assess risk
@nl
prefLabel
Chronic kidney disease in the elderly--how to assess risk
@ast
Chronic kidney disease in the elderly--how to assess risk
@en
Chronic kidney disease in the elderly--how to assess risk
@nl
P356
P1476
Chronic kidney disease in the elderly--how to assess risk
@en
P2093
Andrew S Levey
Lesley A Stevens
P304
P356
10.1056/NEJME058035
P407
P577
2005-05-19T00:00:00Z